Eiki J[au] - Search Results

Year	Number of Results
1987	1
2004	1
2006	2
2007	1
2008	2
2009	10
2010	2
2011	3
2012	1
2013	1
2014	1
2018	1
2019	1
2020	1
2021	2
2022	2
2024	0

1

Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND).

Tajima A, Tobe K, Eiki JI, Origasa H, Watada H, Shimomura I, Tokita S, Kadowaki T. Tajima A, et al. Among authors: eiki ji. BMJ Open Diabetes Res Care. 2022 Dec;10(6):e003032. doi: 10.1136/bmjdrc-2022-003032. BMJ Open Diabetes Res Care. 2022. PMID: 36585033 Free PMC article.

2

Patient characteristics associated with improvement in glycemic control following addition of an oral antidiabetic drug to DPP-4 inhibitor monotherapy in Japanese patients with type 2 diabetes mellitus (JDDM 60).

Kawai K, Eiki JI, Kanatsuka A, Motohashi S, Wakana A, Hayashi A, Iglay K, Yamazaki K, Tokita S, Maegawa H; Japan Diabetes Clinical Data Management Study Group (JDDM). Kawai K, et al. Among authors: eiki ji. Diabetol Int. 2021 Jul 15;13(1):132-141. doi: 10.1007/s13340-021-00514-5. eCollection 2022 Jan. Diabetol Int. 2021. PMID: 35059249 Free PMC article.

3

Comorbidities and complications in Japanese patients with type 2 diabetes mellitus: Retrospective analyses of J-DREAMS, an advanced electronic medical records database.

Ohsugi M, Eiki JI, Iglay K, Tetsuka J, Tokita S, Ueki K. Ohsugi M, et al. Among authors: eiki ji. Diabetes Res Clin Pract. 2021 Aug;178:108845. doi: 10.1016/j.diabres.2021.108845. Epub 2021 Apr 30. Diabetes Res Clin Pract. 2021. PMID: 33933501 Free article.

4

Effect of short-term treatment with sitagliptin or glibenclamide on daily glucose fluctuation in drug-naïve Japanese patients with type 2 diabetes mellitus.

Suzuki R, Eiki JI, Moritoyo T, Furihata K, Wakana A, Ohta Y, Tokita S, Kadowaki T. Suzuki R, et al. Among authors: eiki ji. Diabetes Obes Metab. 2018 Sep;20(9):2274-2281. doi: 10.1111/dom.13364. Epub 2018 Jun 11. Diabetes Obes Metab. 2018. PMID: 29770541 Clinical Trial.

5

The design and optimization of a series of 2-(pyridin-2-yl)-1H-benzimidazole compounds as allosteric glucokinase activators.

Takahashi K, Hashimoto N, Nakama C, Kamata K, Sasaki K, Yoshimoto R, Ohyama S, Hosaka H, Maruki H, Nagata Y, Eiki J, Nishimura T. Takahashi K, et al. Among authors: eiki j. Bioorg Med Chem. 2009 Oct 1;17(19):7042-51. doi: 10.1016/j.bmc.2009.05.037. Epub 2009 May 21. Bioorg Med Chem. 2009. PMID: 19736020

6

Factors associated with the glucose-lowering efficacy of sitagliptin in Japanese patients with type 2 diabetes mellitus: Pooled analysis of Japanese clinical trials.

Tajima N, Eiki JI, Okamoto T, Okuyama K, Kawashima M, Engel SS. Tajima N, et al. Among authors: eiki ji. J Diabetes Investig. 2020 May;11(3):640-646. doi: 10.1111/jdi.13182. Epub 2019 Dec 27. J Diabetes Investig. 2020. PMID: 31743602 Free PMC article. Clinical Trial.

7

Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase.

Kamata K, Mitsuya M, Nishimura T, Eiki J, Nagata Y. Kamata K, et al. Among authors: eiki j. Structure. 2004 Mar;12(3):429-38. doi: 10.1016/j.str.2004.02.005. Structure. 2004. PMID: 15016359 Free article.

8

Discovery and structure-activity relationships of a novel class of quinazoline glucokinase activators.

Iino T, Sasaki Y, Bamba M, Mitsuya M, Ohno A, Kamata K, Hosaka H, Maruki H, Futamura M, Yoshimoto R, Ohyama S, Sasaki K, Chiba M, Ohtake N, Nagata Y, Eiki J, Nishimura T. Iino T, et al. Among authors: eiki j. Bioorg Med Chem Lett. 2009 Oct 1;19(19):5531-8. doi: 10.1016/j.bmcl.2009.08.064. Epub 2009 Aug 21. Bioorg Med Chem Lett. 2009. PMID: 19726182

9

Glucokinase is a critical regulator of ventromedial hypothalamic neuronal glucosensing.

Kang L, Dunn-Meynell AA, Routh VH, Gaspers LD, Nagata Y, Nishimura T, Eiki J, Zhang BB, Levin BE. Kang L, et al. Among authors: eiki j. Diabetes. 2006 Feb;55(2):412-20. doi: 10.2337/diabetes.55.02.06.db05-1229. Diabetes. 2006. PMID: 16443775

10

Impact of small-molecule glucokinase activator on glucose metabolism and beta-cell mass.

Nakamura A, Terauchi Y, Ohyama S, Kubota J, Shimazaki H, Nambu T, Takamoto I, Kubota N, Eiki J, Yoshioka N, Kadowaki T, Koike T. Nakamura A, et al. Among authors: eiki j. Endocrinology. 2009 Mar;150(3):1147-54. doi: 10.1210/en.2008-1183. Epub 2008 Nov 13. Endocrinology. 2009. PMID: 19008318

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

29 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year